title: Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.
authors.forename: Cesare
authors.initials: C
authors.lastname: Mazzaro
authors.forename: Valli
authors.initials: V
authors.lastname: De Re
authors.forename: Michele
authors.initials: M
authors.lastname: Spina
authors.forename: Luigino
authors.initials: L
authors.lastname: Dal Maso
authors.forename: Gianluca
authors.initials: G
authors.lastname: Festini
authors.forename: Consuelo
authors.initials: C
authors.lastname: Comar
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
authors.forename: Gabriele
authors.initials: G
authors.lastname: Pozzato
mesh_terms: D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000821:virology; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a